Excellent long-term pain response and local control following postoperative radiotherapy in patients with multiple myeloma
- Author(s)
- Kaufmann, J; Täubl, AU; Nikolaidou, E; Rühle, A; Hopprich, A; Wollschläger, D; Mayer, A; Nicolay, NH; Schmidberger, H; Bostel, T;
- Details
- Publication Year 2024-07,Volume 200,Issue #7,Page 633-641
- Journal Title
- Strahlentherapie Und Onkologie
- Publication Type
- Research article
- Abstract
- PURPOSE: Multiple myeloma is associated with osteolytic bone lesions, often requiring surgery of the spine and postoperative radiotherapy (RT). Although common, data for clinical and informed decision-making are sparse. In this monocentric retrospective study, we aim to report the outcome of patients who underwent spinal surgery and postoperative RT due to multiple myeloma. METHODS: A total of 54 patients with multiple myeloma who underwent prior spinal surgery and postoperative RT at our institution between 2009 and 2020 were analyzed. Spinal instability neoplastic score (SINS) and Bilsky score, posttherapeutic adverse events, clinical data, and outcomes were collected and analyzed. The primary endpoint of this study was overall survival (OS), secondary endpoints were progression-free survival (PFS), pain response, local control, and skeletal-related events (SRE). RESULTS: The 3‑ and 5‑year overall survival (OS) was 74.9% (95% confidence interval [CI]: 63.5-88.4%) and 58% (95% CI: 44.5-75.6%), respectively. Median survival was not reached and 75% survival was 34.3 months (95% CI: 28.7-95.4 months). Median follow-up was 63 months (95% CI: 49-94 months). The number of patients with good to adequate performance status (Karnofsky performance score [KPS] ≥ 70) significantly increased after surgery (p < 0.01). We observed no grade 3/4 toxicity and only 13 (24%) grade 1/2 adverse events. Two patients (4%) experienced SRE. Overall, 92% of patients reported reduced pain after radiotherapy, with 66% reporting complete pain response. There was no difference in pain response between patients with different Bilsky scores. Bisphosphonate therapy and lower Bilsky score at the start of RT were associated with improved OS in univariate analysis (all p < 0.05). Multivariate Cox regression confirmed a Bilsky score of 2 or 3 as an independent negative prognostic factor (HR 3.89; 95 CI 1.4-10.7; p < 0.01). We observed no in-field recurrences. CONCLUSION: In this study, we were able to show that the current standard of RT after spinal surgery of osteolytic lesions is safe. In addition, we observed a very low rate of SRE (4%) and no in-field recurrences, demonstrating the local efficacy of RT in multiple myeloma patients. Higher Bilsky scores were associated with worse OS in multivariate analysis, but had no effect on pain response.
- Publisher
- Springer Nature
- Keywords
- Humans; *Multiple Myeloma/radiotherapy/mortality; Male; Female; Middle Aged; Aged; Retrospective Studies; Spinal Neoplasms/radiotherapy/surgery/mortality; Aged, 80 and over; Radiotherapy, Adjuvant; Progression-Free Survival; Adult; Treatment Outcome; Cancer Pain/radiotherapy/etiology; Epidural spine compression score; Osteolytic lesions; Skeletal related events; Spinal bone lesions; Spinal surgery
- Department(s)
- Radiation Oncology
- Publisher's Version
- https://doi.org/10.1007/s00066-024-02198-7
- Open Access at Publisher's Site
https://doi.org/10.1007/s00066-024-02198-7- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2024-08-06 05:34:01
Last Modified: 2024-08-06 05:34:17